GURUFOCUS.COM » STOCK LIST » Industrials » Conglomerates » Protect Pharmaceutical Corp (OTCPK:PRTT) » Definitions » EV-to-Revenue

Protect Pharmaceutical (Protect Pharmaceutical) EV-to-Revenue

: (As of Today)
View and export this data going back to 2006. Start your Free Trial

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Protect Pharmaceutical's enterprise value is $3.13 Mil. Protect Pharmaceutical's Revenue for the trailing twelve months (TTM) ended in Jun. 2018 was $0.00 Mil. Therefore, Protect Pharmaceutical's EV-to-Revenue for today is .

The historical rank and industry rank for Protect Pharmaceutical's EV-to-Revenue or its related term are showing as below:

PRTT's EV-to-Revenue is not ranked *
in the Conglomerates industry.
Industry Median: 1.17
* Ranked among companies with meaningful EV-to-Revenue only.

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-04-19), Protect Pharmaceutical's stock price is $2.77. Protect Pharmaceutical's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2018 was $0.00. Therefore, Protect Pharmaceutical's PS Ratio for today is .


Protect Pharmaceutical EV-to-Revenue Historical Data

The historical data trend for Protect Pharmaceutical's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Protect Pharmaceutical Annual Data
Trend Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17
EV-to-Revenue
Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Protect Pharmaceutical Quarterly Data
Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18
EV-to-Revenue Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison

For the Conglomerates subindustry, Protect Pharmaceutical's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Protect Pharmaceutical EV-to-Revenue Distribution

For the Conglomerates industry and Industrials sector, Protect Pharmaceutical's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Protect Pharmaceutical's EV-to-Revenue falls into.



Protect Pharmaceutical EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Protect Pharmaceutical's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=3.127/0
=

Protect Pharmaceutical's current Enterprise Value is $3.13 Mil.
Protect Pharmaceutical's Revenue for the trailing twelve months (TTM) ended in Jun. 2018 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Protect Pharmaceutical  (OTCPK:PRTT) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Protect Pharmaceutical's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=2.77/0
=

Protect Pharmaceutical's share price for today is $2.77.
Protect Pharmaceutical's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2018 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Protect Pharmaceutical EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Protect Pharmaceutical's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Protect Pharmaceutical (Protect Pharmaceutical) Business Description

Traded in Other Exchanges
N/A
Address
12465 South Street, Suite 240, Draper, UT, USA, 84020
Protect Pharmaceutical Corp has an organic solution to soil and crop protection, annual growth, and natural restoration upon the completion of crop cycles. The company uses its products to revitalize farming soil, produce organic, toxin-free crops, and meet the increasing global demand for agricultural sustainability initiatives.